THOMAS K. LEACH
*** ****** **., ******, ** ***** 1-570-***-**** abh487@r.postjobfree.com
ACCOUNT EXECUTIVE / TECHNICAL CONSULTANT
North American Sales
Senior account executive with a record of success at growing organization sales with integral interaction
with product design, testing, manufacturing, market launch and distribution. Experience and interests are
well suited to a corporate national, regional or division management role. Offering value in the following
areas:
Distributor Network Development – Assisted in the development of a multi-disciplined sales process,
hired and trained the sales team, and identified, secured and trained a distributor network across 6 states.
Marketing – Successful at marketing complex scientific and engineering concepts to government
agencies (FDA and the Office of Science Technology Policy at the White House), hospitals, and
professional healthcare and engineering associations.
Organizational Startup – Assisted in the startup of a medical device manufacturer to $1.6 in annual
sales.
Product Development and Launch – Assisted in the concept and development of new technology
for health care and homeland security markets that are used by the federal government and Fortune
500 companies today.
Product Sales – Introduced and sold to government and private entities including U.S. Government,
Federal Reserve Bank and AIG.
EXPERIENCE AND ACCOMPLISHMENTS
GENERAL AIRE SYSTEMS INC. – Darby, PA 2012 to 2014
General Aire Systems, Inc. was founded in 2003 as a representative/distributor and service provider for air
purification systems.
Senior Account Executive/Technical Consultant
Assisted in the ongoing development of General Aire Systems ultra violet germicidal irradiation technology
for air purification and disinfection. Focused on hospitals and healthcare systems to reduce hospital acquired
infections. Additionally private and public instituitions and businesses for implementation of IAQ systems.
Developed the annual qualification verification and certification for all ongoing UVGI installations.
VIGILAIR SYSTEMS INC. – North Tonawanda, NY 2003 to 2012
VIGILAR Systems, Inc. was founded in 2003 as a manufacturer of an air purification system. Systems were
engineered and manufactured for indoor air treatment.
Senior Account Executive/Technical Consultant
Assisted in the conception and development of VIGILAIR®, a new and innovative technology for air
purification and disinfection. The product is currently used in hospitals to reduce hospital acquired infections
and in government office buildings for pandemic preparedness and defense from potential bio-terrorism.
Personally responsible for market development and commercialization, and overseeing the identification,
selection and training of a regional sales and service distribution network.
Thomas K. Leach Page 2 of 4
Assisted in taking innovative product from concept to marketable product. Assisted in the
completion of the first product clinical trial for product at Women and Children’s Hospital of
Buffalo.
Contributed to increased sales from $700,000 in 2003 to $1.6 million in 2004, maintaining those sales levels,
despite impact of the general economic downturn and recent downturn in the healthcare marketplace.
Assisted in the development of a multi-disciplined sales concept to introduce product to the
Healthcare Market. Secured contracts for VIGILAIR® in over 50 Hospital Systems in 13 states and
DC, generating sales to hospitals of $2.0-2.5 million.
Met with Department of Homeland Security Director of Office of Science and Technology Policy
for the President of the United States. Meeting lead to the application and award of Qualified Anti
Terrorism Technology designation for VIGILAIR®, under the Department of Homeland Security.
Secured contracts for bio defense product with the Federal Reserve Banks, AIG Corporation, and
the Federal Government, resulting in sales of $2.5-3.0 million.
Assisted in the development of distribution network; identifying, signing and training 13
professional manufacturer representative firms covering 17 states, generating a 40% increase in sales
for five consecutive quarters until the economic downturn occurred.
In 2001 led coordination and implementation of the first UVGI system into a sub Class 1
semiconductor process ventilation system at IBM’s East Fishkill, New York facility. This technology
enabled IBM to successfully maintain FAB conditions and to exceed SEMI specifications.
Worked with the U.S. General Services Administration in the application of VIGILAIR technology in
building ventilation systems defense against potential bio-terrorist attacks. The first installation was
completed at U.S. General Services Administration project in lower Manhattan in June of 2002.
December of 2005 and continuing through 2007 involved with AIG Corporation Real Estate Managers
and Engineers designing and implementing the Building Hardening and Shelter in Place Programs.
This process included assisting the AIG external design, security, and environmental team of Lakhani &
Jordan, PC, Assessment & Technologies, LLC and James Lee Associates in assessment of all AIG
Manhattan locations resulting in VIGILAIR technology being selected as HVAC protection of choice and
utilization in all AIG lower Manhattan locations. Working relationship with AIG Business Continuity
Group in introducing VIGILAIR to AIG’s external clients.
Starting in October of 2001 and continuing through 2007 involved with the Federal Reserve Bank of New
York (FRBNY) Real Estate Managers in it’s building Hardening and Business Continuity planning The
FRBNY used a very similar assessment strategy as AIG; employing its internal resources with those of
external consultants. The Federal Reserve’s two year analyses resulted in VIGILAIR technology being
selected as HVAC protection of choice and utilization in lower Manhattan. In addition, FRBNY has
introduced VIGILAIR to the Federal Reserve Board of Governors with recommendations of broad use of
the VIGILAIR technology a part of an overall strategy of business continuity under Extraordinary
Circumstance such as a terrorist attack or pandemic outbreak.
Beginning in 2006 worked with United Nations Facility Engineering and Syska and Hennessey,
Project Engineer of record, on the UN refurbishment project. Along with the VIIGLAIR applications
engineers have been working closely with the Syska design team in integrating VIGILAIR into the
construction project. This work has resulted in VIGILAIR being named as the basis of design for the
HVAC system protection equipment.
Assisted in the December 2008 approval from Georgetown University Hospital Center for a 12 month study,
funded by Georgetown, of VIGILAIR product to reduce Hospital Acquired Infections in the Neonatal Intensive
Care Unit. Based upon the positive results Georgetown University Hospital is in the process of planning for
installation of $200,000 VIGILAIR product in all Patient Critical Care areas in the Hospital for 2010.
Worked with the New York City Fire Department and the New York/New Jersey Ports Authority
identifying the uses of VIGILAIR within their Department and other Departments within the New
Thomas K. Leach Page 3 of 4
York City Government. This has resulted with the Port Authority identifying the use of VIGILAIR
throughout the New York/New Jersey Port Authority’s Infrastructure.
March 2010 assisted in the proposed to Hartford Hospital Neuro Trauma Surgical/Intensive Care Staff and
received Approval for a study of VIGILAIR product to reduce infect ions in the Neuro-Trauma ICU. Positive
Study results will move Hartford to install VIGILAIR in all Patient critical care area HVAC systems.
FP TECHNOLOGIES, INC. – North Tonawanda, NY 1993 to 2002
FP Technologies, Inc. was a privately held engineering contracting and service business specializing in cleanroom
design and construction, contamination identification, and clean protocol manufacturing process development.
Senior Account Executive/Technical Consultant
While at FP Technologies, assisted in conducting an extensive analysis of manufacturing processes, environment
and personnel, and developed a process to systemically identify potential sources of contamination causing
product failure.
Sales tripled at FP Technologies from $1.2 million in 1989 to $3 million in 2002.
Assisted in securing lucrative contracts to provide manufacturing process improvement
engineering services for Fortune 500 companies. The work performed by FP Technologies
identified and designed process improvements that resulted in product yield savings of over $3
million per year for Kodak, and over $7 million per year for Lexmark.
In 1996 coordinated a contamination audit at Nortel Networks digital switch program in Nepean,
Ontario. The audit revealed defects directly related to contamination through manual and
automated handling. The engineered retrofits that were implemented within process flow included
improved operator protocols and room, tool and in-line ionization. The customer realized an annual
yield improvement of 4% from the process changes.
Developed an electrostatic program with General Electric for conductive air within process tooling
at the R&D facility in Niskayuna, New York (1996-Present). The results have been decreased defects
and increased throughputs due to reduction of particle attraction and electrostatic discharge.
In 1999 assisted in determining market need, following extensive market analysis, to predictably
reduce airborne microorganism contamination in indoor environments, and conceived of a Germicidal
Ultraviolet Irradiation (UVGI) and filtration product that was adaptable to indoor environments.
Assisted in introducing the concept and proposal of a study to the University at Buffalo and
Women and Children’s of Buffalo Hospital (WCHOB) in 2000 focusing on the application of UVGI
in HVAC to reduce Hospital Acquired Infections. A $1.0 million grant from the New York State
Center for Advanced Technology to conduct the study at WCHOB was secured.
Based upon the positive results of the Study in reducing Hospital Acquired infections WCHOB
placed a $250,000 Contract with FP Technologies to install equipment in all Critical Patient Care
areas within the Hospital. The Abstract for the Study was presented at the Pediatric Academic
Society (PAS) Conference, Seattle, WA, May 2003.
Wyeth Pharmaceutical met the WCHOB Researchers at the PAS Conference and contacted VIGILAIR for
application of the product in baby formula manufacturing. The resulting meetings resulted in Contracts of over
$2 million for VIGILAIR installations in Wyeth Plants in the U.S., China, Mexico, Philippines and Singapore.
Assets of FP Technology were sold in order to finance the start up of VIGILAIR Systems in 2002.
EDUCATION AND PROFESSIONAL DEVELOPMENT
NIAGARA COUNTY COMMUNITY COLLEGE- Niagara Falls, NY
Associates Degree in Science, 1982
STATE UNIVERSITY OF NEW YORK AT BUFFALO – Buffalo, New York
Bachelor of Science, 1985
Thomas K. Leach Page 4 of 4
CLARKSON UNIVERSITY – Potsdam, NY
Postgraduate studies, 1996
AMERICAN SOCIETY OF HEATING, REFRIGERATING AND AIR CONDITIONING ENGINEERS
Member, 2009 to Present
INTERESTS / ACTIVITIES
Interests include American and World history, aeronautical and aviation history, chronological development
of the auto industry and ice hockey. Actively involved in young person’s league soccer programs.